McKeever, TriciaMortimer, KevinWilson, AndrewWalker, SamanthaBrightling, ChristopherSkeggs, AndrewPavord, Ian D.Price, David B.Duley, LeliaThomas, MikeBradshaw, LucyHiggins, BernardHaydock, RebeccaMitchell, Eleanor JDevereux, GrahamHarrison, Timothy2018-09-032018-09-032018-03-08McKeever, T, Mortimer, K, Wilson, A, Walker, S, Brightling, C, Skeggs, A, Pavord, I D, Price, D B, Duley, L, Thomas, M, Bradshaw, L, Higgins, B, Haydock, R, Mitchell, E J, Devereux, G & Harrison, T 2018, 'Quadrupling Inhaled Gluococorticoid Dose To Abort Asthma Exacerbations', The New England Journal of Medicine, vol. 378, no. 10, pp. 902-910. https://doi.org/10.1056/NEJMoa17142570028-4793http://hdl.handle.net/2164/11041Supported by the Health Technology Assessment Programme of the National Institute for Health Research. We thank the trial participants, all the staff at the trial sites and the Nottingham Clinical Trial Unit who managed the trial, the members of the independent trial steering committee (Philip Ind [chair], consultant respiratory physician, Imperial College Healthcare NHS Trust; Adel Mansur, consultant physician, Birmingham Heartlands Hospital; Jacqui Cooper, chronic obstructive pulmonary disease–respiratory team leader, Keyworth Primary Care Centre; and Kim-Leng Hills, patient representative), and the members of the independent data monitoring committee (Steven Julious [chair], professor of medical statistics, University of Sheffield; Ian Sabroe, professor of inflammation biology, University of Sheffield; and Stephen Scott, consultant respiratory physician, Countess of Chester Hospital).9276741engR Medicine (General)National Institute for Health Research (NIHR)ISRCTN15441965R1Journal article10.1056/NEJMoa171425737810